Paolo Pucci

Former Chief Executive Officer & Director at ArQule, Inc.

Paolo Pucci

Paolo Pucci

Former Chief Executive Officer & Director at ArQule, Inc.

Overview
Career Highlights

Bayer AG
ArQule, Inc.

RelSci Relationships

708

Number of Boards

7

Birthday

1962

Age

58

Relationships
RelSci Relationships are individuals Paolo Pucci likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Executive Chairman of the Board & Interim Chief Executive Officer at EXACT Sciences Corp.

Relationship likelihood: Strong

Former Chief Medical Officer at The Multiple Myeloma Research Foundation, Inc.

Relationship likelihood: Strong

Lecturer, Business Ethics at Holy Cross College

Relationship likelihood: Strong

Co-Founder at Zebra Biologics, Inc.

Relationship likelihood: Strong

Former Finance Director at Ciba Geigy Corp.

Relationship likelihood: Strong

Former Chief Executive Officer at NitroMed, Inc.

Relationship likelihood: Strong

Chief Executive Officer, President & Director at West Pharmaceutical Services Inc.

Relationship likelihood: Strong

Oncologist at Epic Care

Relationship likelihood: Strong

Co-Founder & Managing Partner at Pontifax Management Co. Ltd.

Relationship likelihood: Strong

President, Treasurer & Director at Shire Human Genetic Therapies, Inc.

Relationship likelihood: Strong

Paths to Paolo Pucci
Potential Connections via
Relationship Science
You
Paolo Pucci
Former Chief Executive Officer & Director at ArQule, Inc.
Education
Master of Business Administration (MBA)

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

University of Naples Federico II is a school in Naples.

Career History
Chief Executive Officer & Director
2008 - Current

ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751 and Derazantinib products. The company was founded in 1993 and is headquartered in Burlington, MA.

President
2001 - 2008

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Managing Director
Prior
Boards & Committees
Member of the Bayer Pharmaceuticals Global Management Committee
Prior

Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paolo Pucci. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paolo Pucci's profile does not indicate a business or promotional relationship of any kind between RelSci and Paolo Pucci.